Orphan Drugs Nefecon, Maribavir & Copanlisib Among New EU Filings
US Filings For The Orphan Drugs Are Under Review
Marketing applications for two generic versions of the multiple sclerosis blockbuster, Tecfidera, are also under review by the European Medicines Agency.
